These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37740072)

  • 1. Fabrication and Characterization of Antibody-Loaded Cationic Porous PLGA Microparticles for Sustained Antibody Release.
    Hanaki A; Ogawa K; Tagami T; Ozeki T
    AAPS J; 2023 Sep; 25(6):92. PubMed ID: 37740072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model.
    Oh YJ; Lee J; Seo JY; Rhim T; Kim SH; Yoon HJ; Lee KY
    J Control Release; 2011 Feb; 150(1):56-62. PubMed ID: 21070826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of poly (lactic-co-glycolic acid)-poly ethyleneimine-plasmid DNA microparticles prepared using double emulsion methods.
    Zhang XQ; Intra J; Salem AK
    J Microencapsul; 2008 Feb; 25(1):1-12. PubMed ID: 18188727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
    Keohane K; Brennan D; Galvin P; Griffin BT
    Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells.
    Intra J; Salem AK
    J Drug Target; 2011 Jul; 19(6):393-408. PubMed ID: 20681752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of porous poly(lactic-co-glycolic acid) microparticles by electrospray deposition method for controlled drug release.
    Hao S; Wang Y; Wang B; Deng J; Zhu L; Cao Y
    Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():113-9. PubMed ID: 24863206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan.
    Li Z; Xiong F; He J; Dai X; Wang G
    Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterization.
    Ni R; Muenster U; Zhao J; Zhang L; Becker-Pelster EM; Rosenbruch M; Mao S
    J Control Release; 2017 Mar; 249():11-22. PubMed ID: 28109773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved porosity of electrospun poly (Lactic-Co-Glycolic) scaffolds by sacrificial microparticles enhances cellular infiltration compared to sacrificial microfiber.
    Hodge JG; Quint C
    J Biomater Appl; 2022 Jul; 37(1):77-88. PubMed ID: 35317691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 12. Cannabidiol-loaded microparticles embedded in a porous hydrogel matrix for biomedical applications.
    David C; de Souza JF; Silva AF; Grazioli G; Barboza AS; Lund RG; Fajardo AR; Moraes RR
    J Mater Sci Mater Med; 2024 Feb; 35(1):14. PubMed ID: 38353746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
    Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
    Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery.
    Intra J; Salem AK
    J Pharm Sci; 2010 Jan; 99(1):368-84. PubMed ID: 19670295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric microparticles for sustained and local delivery of antiCD40 and antiCTLA-4 in immunotherapy of cancer.
    Rahimian S; Fransen MF; Kleinovink JW; Amidi M; Ossendorp F; Hennink WE
    Biomaterials; 2015 Aug; 61():33-40. PubMed ID: 25993015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
    Zhu X; Lu L; Currier BL; Windebank AJ; Yaszemski MJ
    Biomaterials; 2002 Jul; 23(13):2683-92. PubMed ID: 12059017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin-loaded porous PLGA microparticles with surface attached TRAIL for the inhalation treatment of metastatic lung cancer.
    Kim I; Byeon HJ; Kim TH; Lee ES; Oh KT; Shin BS; Lee KC; Youn YS
    Biomaterials; 2013 Sep; 34(27):6444-53. PubMed ID: 23755831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and optimization of PLGA microparticles for controlled and local delivery of Neuregulin-1 in traumatic spinal cord injury.
    Santhosh KT; Alizadeh A; Karimi-Abdolrezaee S
    J Control Release; 2017 Sep; 261():147-162. PubMed ID: 28668379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin.
    Nan K; Ma F; Hou H; Freeman WR; Sailor MJ; Cheng L
    Acta Biomater; 2014 Aug; 10(8):3505-12. PubMed ID: 24793657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.